Denosumab Versus Oral Bisphosphonate (Alendronate) for Osteoporosis in Long-term Glucocorticoid Users: an Open Randomized Controlled Trial
Not yet recruiting
Phase of Trial: Phase IV
Latest Information Update: 21 Apr 2017
At a glance
- Drugs Denosumab (Primary) ; Alendronic acid
- Indications Osteoporosis
- Focus Therapeutic Use
- 16 Apr 2017 Planned End Date changed from 1 Dec 2019 to 1 Feb 2020.
- 16 Apr 2017 Planned primary completion date changed from 1 Apr 2019 to 1 Jun 2019.
- 03 Jan 2017 New trial record